Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Pfizer
Avera McKennan Hospital & University Health Center
M.D. Anderson Cancer Center
Cancer Research UK
University of Florida
M.D. Anderson Cancer Center
University of Salamanca
Cancer Research UK
Cancer Research UK
Incyte Corporation
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Dana-Farber Cancer Institute
Arbeitsgemeinschaft medikamentoese Tumortherapie
Inova Health Care Services
Shenzhen TargetRx Co., Ltd.
Ipsen
National Cancer Institute (NCI)
Pfizer
MacroGenics
Global BioClinical
AbbVie
Fred Hutchinson Cancer Center
Seoul National University Hospital
Pfizer
Celgene
Novartis
Incyte Corporation
CureOne
Incyte Corporation
Novartis
National Cancer Institute (NCI)